169 related articles for article (PubMed ID: 31389607)
1. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer.
Zhang Q; Bian SQ; Lv W; Kou D; Hu HL; Guo SS; Cao ZS
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):239-246. PubMed ID: 31389607
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Efficiency of TACE plus HIFU and TACE alone on Patients with Primary Liver Cancer.
Luo Y; Jiang Y
J Coll Physicians Surg Pak; 2019 May; 29(5):414-417. PubMed ID: 31036108
[TBL] [Abstract][Full Text] [Related]
3. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
[TBL] [Abstract][Full Text] [Related]
4. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
[TBL] [Abstract][Full Text] [Related]
5. High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer.
Sun M; Shang P; Bai J; Li S; Li M
J Clin Lab Anal; 2021 Feb; 35(2):e23633. PubMed ID: 33099812
[TBL] [Abstract][Full Text] [Related]
6. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
Kim J; Chung DJ; Jung SE; Cho SH; Hahn ST; Lee JM
Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
[TBL] [Abstract][Full Text] [Related]
8. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
9. Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
Lai X; Wang A
Comput Intell Neurosci; 2022; 2022():6336107. PubMed ID: 36052044
[TBL] [Abstract][Full Text] [Related]
10. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Lenvatinib in Combination With PD-1 Monoclonal Antibody and Interventional Treatment for Intermediate-Stage Hepatocellular Carcinoma: Impact on Serum Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 Levels: A Retrospective Study.
Zhu J; Wu Y; Zhang H; Yang J; An Y; Shao S; Xia N
Technol Cancer Res Treat; 2024; 23():15330338241256812. PubMed ID: 38802996
[No Abstract] [Full Text] [Related]
12. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
[TBL] [Abstract][Full Text] [Related]
13. Effect of the combination treatment of high-intensity focused ultrasound and cryocare knife in advanced liver cancer.
Zhai YP; Wang Y
J BUON; 2017; 22(2):495-499. PubMed ID: 28534375
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of bevacizumab combined with nedaplatin in the treatment of ovarian cancer and its effects on tumor markers and immunity of patients.
Zhang H; Chen C; Wang S; Li X; Fan T
J BUON; 2020; 25(1):80-86. PubMed ID: 32277617
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of licartin combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced primary liver cancer.
Jin J; Zhou T; Lou J; Yan S; Wu Y; Xie M; Wang W
J BUON; 2020; 25(6):2584-2591. PubMed ID: 33455100
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma.
Liu Q; Dai Y
J BUON; 2020; 25(2):945-951. PubMed ID: 32521890
[TBL] [Abstract][Full Text] [Related]
17. Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.
Fan J; He S; Zheng Y
J BUON; 2019; 24(6):2411-2417. PubMed ID: 31983113
[TBL] [Abstract][Full Text] [Related]
18. Reduced glutathione ameliorates liver function, oxidative stress and inflammation after interventional therapy for hepatocellular carcinoma.
Ke Y; Wu T; Lei X; Zhang C; Zhou J; Li J; Zhang H; Chen X; Wang J; Wang L
J BUON; 2020; 25(3):1361-1367. PubMed ID: 32862577
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma.
Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of high-intensity focused ultrasound ablation for hepatocellular carcinoma by changing the acoustic environment: microbubble contrast agent (SonoVue) and transcatheter arterial chemoembolization.
Huang L; Zhou K; Zhang J; Ma Y; Yang W; Ran L; Jin C; Dimitrov DD; Zhu H
Int J Hyperthermia; 2019; 36(1):244-252. PubMed ID: 30668189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]